Quick Summary:
In the ever-evolving industry of cardiac health, it's essential to have access to detailed, reliable information, especially when it comes to pivotal areas like cardiac implantable electronic devices. These devices – pacemakers, defibrillators and cardiac rhythm monitors – play crucial roles in managing cardiac disorders including arrhythmias and heart rhythm disorders, thus enhancing patient's quality of life.
This comprehensive market research report offers an in-depth analysis of the global cardiac implantable electronic device market, highlighting everything from market drivers and restraints to new product launches and competitive strategies adopted by key players. Stay ahead of the industry curve with insights that will inform your future product launches, market expansion, and marketing tactics. Whether you're an investor, supplier, product manufacturer, distributor, or just breaking into the field, this report is an invaluable tool in your decision-making process, equipping you with the knowledge to navigate this critical sector of cardiac health industry with confidence.
Cardiac implants are devices that are implanted in the heart tissue, in order to control irregular heart function. Cardiac implants such as pacemakers, defibrillator implants, and cardiac rhythm monitoring implants are available in the market to treat cardiac dysfunction such as heart rhythm disorders, arrhythmias, and other heart related disorders. These cardiac implants are majorly prescribed to patients with heart failure. Cardiac implants have been developed with innovative technical features in the recent years, and this has improved quality of life of patients with heart failure. A pacemaker insertion is the implantation of a small electronic device that is usually placed in the chest (just below the collarbone) to regulate slow electrical problems related to heart. A pacemaker can be recommended to ensure that the heartbeat does not slow to a dangerously low rate. There are three kind of pacemakers: single chamber- one lead attaches to the upper or lower heart chamber, dual-chamber- it uses two leads, one for the upper and one for the lower chamber, and biventricular pacemakers that is used in cardiac resynchronization therapy. An implantable cardioverter-defibrillator (ICD) is a small battery-powered device that is placed in the chest to detect, and to stop irregular heartbeats (arrhythmias). An ICD continuously monitors the heartbeat and delivers electric shocks, when needed, to restore a regular heart rhythm. Increasing incidence of cardiac arrhythmia, aging population, and demographic changes are expected to drive the global cardiac implantable electronic device market growth over the forecast period.
Market Dynamics
Increasing prevalence of cardiovascular diseases such as cardiac arrhythmia, coronary artery disease, and others, aging population, and demographic changes are expected to drive the global cardiac implantable electronic device market growth over the forecast period. For instance, on May 15, 2023, according to the Centers for Disease Control and Prevention, in the U.S., heart disease caused around 695,000 deaths in 2021, accounting for 1 in every 5 fatalities and around 1 in 20 adults aged 20 and older have coronary artery disease (CAD).Key features of the study:
- This report provides in-depth analysis of the global cardiac implantable electronic device market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cardiac implantable electronic device market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study are Medtronic, Biotronik, Boston Scientific Corporation or its affiliates, Pacetronix.com, Integer Holdings Corporation, Cook Group, Braile Biomédica, Abbott, LivaNova PLC, OSYPKA Medical, Galix Biomedical Instrumentation Inc., OSCOR Inc., LifeTech Scientific Corporation, MicroPort Scientific Corporation, and Ceryx Medical
- Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global cardiac implantable electronic device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts :
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac implantable electronic device market.
Detailed Segmentation:
Global Cardiac Implantable Electronic Device Market, By Type:
- Implantable Pacemakers
- External Pacemakers
Global Cardiac Implantable Electronic Device Market By End User:
- Hospitals
- Specialty Clinics
- Ambulatory Care Settings
Global Cardiac Implantable Electronic Device Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Medtronic
- Biotronik
- Boston Scientific Corporation or its affiliates
- Pacetronix.com
- Integer Holdings Corporation
- Cook Group
- Braile Biomédica
- Abbott
- LivaNova PLC
- OSYPKA Medical
- Galix Biomedical Instrumentation Inc.
- OSCOR Inc.
- LifeTech Scientific Corporation
- MicroPort Scientific Corporation
- Ceryx Medical
Frequently Asked Questions about the Global Sprycel Market
What is the estimated value of the Global Sprycel Market?
What is the growth rate of the Global Sprycel Market?
What is the forecasted size of the Global Sprycel Market?
Who are the key companies in the Global Sprycel Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 195 |
| Published | July 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 28.1 Billion |
| Forecasted Market Value ( USD | $ 47.4 Billion |
| Compound Annual Growth Rate | 7.8% |
| Regions Covered | Global |
Table of Contents
1. Research Objectives and Assumptions
2. Market Overview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Cardiac Implantable Electronic Device Market- COVID-19 Impact Analysis
5. Global Cardiac Implantable Electronic Device Market, By Type, 2018-2030, (US$ Billion)
6. Global Cardiac Implantable Electronic Device Market, By End User, 2018-2030, (US$ Billion)
7. Global Cardiac Implantable Electronic Device Market, By Region, 2018-2030, (US$ Billion)
8. Competitive Landscape
9. Section
Companies Mentioned
A selection of companies mentioned in this report includes:
- Medtronic
- Biotronik
- Boston Scientific Corporation or its affiliates
- Pacetronix.com
- Integer Holdings Corporation
- Cook Group
- Braile Biomédica
- Abbott
- LivaNova PLC
- OSYPKA Medical
- Galix Biomedical Instrumentation Inc.
- OSCOR Inc.
- LifeTech Scientific Corporation
- MicroPort Scientific Corporation
- Ceryx Medical
